Global Molecular Diagnostics in Cancer Testing Market Research Report 2018 by Manufacturers, Regions, Types and Applications

Table of Contents

1 Report Overview

• 1.1 Definition and Specification
• 1.2 Report Overview
  • 1.2.1 Manufacturers Overview
  • 1.2.2 Regions Overview
  • 1.2.3 Type Overview
  • 1.2.4 Application Overview
• 1.3 Industrial Chain
  • 1.3.1 Molecular Diagnostics in Cancer Testing Overall Industrial Chain
  • 1.3.2 Upstream
  • 1.3.3 Downstream
• 1.4 Industry Situation
  • 1.4.1 Industrial Policy
  • 1.4.2 Product Preference
  • 1.4.3 Economic/Political Environment
• 1.5 SWOT Analysis

2 Market Analysis by Types

• 2.1 Overall Market Performance
  • 2.1.1 Product Type Market Performance (Volume)
  • 2.1.2 Product Type Market Performance (Value)
• 2.2 China Molecular Diagnostics in Cancer Testing Market Performance
• 2.3 USA Molecular Diagnostics in Cancer Testing Market Performance
• 2.4 Europe Molecular Diagnostics in Cancer Testing Market Performance
• 2.5 Japan Molecular Diagnostics in Cancer Testing Market Performance
• 2.6 Korea Molecular Diagnostics in Cancer Testing Market Performance
• 2.7 India Molecular Diagnostics in Cancer Testing Market Performance
• 2.8 Southeast Asia Molecular Diagnostics in Cancer Testing Market Performance
• 2.9 South America Molecular Diagnostics in Cancer Testing Market Performance

3 Product Application Market

• 3.1 Overall Market Performance (Volume)
• 3.2 China Molecular Diagnostics in Cancer Testing Market Performance (Volume)
• 3.3 USA Molecular Diagnostics in Cancer Testing Market Performance (Volume)
• 3.4 Europe Molecular Diagnostics in Cancer Testing Market Performance (Volume)
• 3.5 Japan Molecular Diagnostics in Cancer Testing Market Performance (Volume)
• 3.6 Korea Molecular Diagnostics in Cancer Testing Market Performance (Volume)
• 3.7 India Molecular Diagnostics in Cancer Testing Market Performance (Volume)
• 3.8 Southeast Asia Molecular Diagnostics in Cancer Testing Market Performance (Volume)
• 3.9 South America Molecular Diagnostics in Cancer Testing Market Performance (Volume)

4 Manufacturers Profiles/Analysis

• 4.1 Abbott Molecular Diagnostics
  • 4.1.1 Abbott Molecular Diagnostics Profiles
  • 4.1.2 Abbott Molecular Diagnostics Product Information
  • 4.1.3 Abbott Molecular Diagnostics Molecular Diagnostics in Cancer Testing Business Performance
  • 4.1.4 Abbott Molecular Diagnostics Molecular Diagnostics in Cancer Testing Business Development and Market Status
• 4.2 Accugenomics
  • 4.2.1 Accugenomics Profiles
  • 4.2.2 Accugenomics Product Information
  • 4.2.3 Accugenomics Molecular Diagnostics in Cancer Testing Business Performance
  • 4.2.4 Accugenomics Molecular Diagnostics in Cancer Testing Business Development and Market Status
• 4.3 Agendia
  • 4.3.1 Agendia Profiles
  • 4.3.2 Agendia Product Information
  • 4.3.3 Agendia Molecular Diagnostics in Cancer Testing Business Performance
  • 4.3.4 Agendia Molecular Diagnostics in Cancer Testing Business Development and Market Status
• 4.4 Ambry Genetics
  • 4.4.1 Ambry Genetics Profiles
  • 4.4.2 Ambry Genetics Product Information
  • 4.4.3 Ambry Genetics Molecular Diagnostics in Cancer Testing Business Performance
  • 4.4.4 Ambry Genetics Molecular Diagnostics in Cancer Testing Business Development and Market Status
• 4.5 Biodesix
  • 4.5.1 Biodesix Profiles
  • 4.5.2 Biodesix Product Information
  • 4.5.3 Biodesix Molecular Diagnostics in Cancer Testing Business Performance
  • 4.5.4 Biodesix Molecular Diagnostics in Cancer Testing Business Development and Market Status
• 4.6 bioMerieux
  • 4.6.1 bioMerieux Profiles
  • 4.6.2 bioMerieux Product Information
  • 4.6.3 bioMerieux Molecular Diagnostics in Cancer Testing Business Performance
  • 4.6.4 bioMerieux Molecular Diagnostics in Cancer Testing Business Development and Market Status
• 4.7 bioTheranostics (AviaraDx)
  • 4.7.1 bioTheranostics (AviaraDx) Profiles
  • 4.7.2 bioTheranostics (AviaraDx) Product Information
  • 4.7.3 bioTheranostics (AviaraDx) Molecular Diagnostics in Cancer Testing Business Performance
  • 4.7.4 bioTheranostics (AviaraDx) Molecular Diagnostics in Cancer Testing Business Development and Market Status
• 4.8 Cancer Genetics
  • 4.8.1 Cancer Genetics Profiles
  • 4.8.2 Cancer Genetics Product Information
  • 4.8.3 Cancer Genetics Molecular Diagnostics in Cancer Testing Business Performance
  • 4.8.4 Cancer Genetics Molecular Diagnostics in Cancer Testing Business Development and Market Status
• 4.9 Clarient, Inc. (GE Healthcare)
  • 4.9.1 Clarient, Inc. (GE Healthcare) Profiles
  • 4.9.2 Clarient, Inc. (GE Healthcare) Product Information
  • 4.9.3 Clarient, Inc. (GE Healthcare) Molecular Diagnostics in Cancer Testing Business Performance
  • 4.9.4 Clarient, Inc. (GE Healthcare) Molecular Diagnostics in Cancer Testing Business Development and Market Status
• 4.10 Counsyl
  • 4.10.1 Counsyl Profiles
  • 4.10.2 Counsyl Product Information
  • 4.10.3 Counsyl Molecular Diagnostics in Cancer Testing Business Performance
  • 4.10.4 Counsyl Molecular Diagnostics in Cancer Testing Business Development and Market Status
• 4.11 Flatiron Health
• 4.12 Epigenomics
• 4.13 Agendia
• 4.14 Ambry Genetics
• 4.15 Biodesix
• 4.20 Counsyl

5 Market Performance for Manufacturers

• 5.1 Global Molecular Diagnostics in Cancer Testing Production (K Units) and Market Share by Manufacturers 2013-2018
• 5.2 Global Molecular Diagnostics in Cancer Testing Revenue (M USD) and Market Share by Manufacturers 2013-2018
• 5.3 Global Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers 2013-2018
• 5.4 Global Molecular Diagnostics in Cancer Testing Gross Margin of Manufacturers 2013-2018
• 5.5 Market Concentration

6 Global Molecular Diagnostics in Cancer Testing Market Performance (Production Point)

• 6.1 Global Molecular Diagnostics in Cancer Testing Production (K Units) and Market Share by Regions 2013-2018
• 6.2 Global Molecular Diagnostics in Cancer Testing Revenue (M USD) and Market Share by Regions 2013-2018
• 6.3 Global Molecular Diagnostics in Cancer Testing Price (USD/Unit) by Regions 2013-2018
• 6.4 Global Molecular Diagnostics in Cancer Testing Gross Margin by Regions 2013-2018

7 Development Trend for Regions (Production Point)

• 7.1 Global Molecular Diagnostics in Cancer Testing Production (K Units), Revenue (&$B$8&) and Growth Rate 2013-2018
• 7.2 China Molecular Diagnostics in Cancer Testing Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
• 7.3 USA Molecular Diagnostics in Cancer Testing Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
• 7.4 Europe Molecular Diagnostics in Cancer Testing Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
• 7.5 Japan Molecular Diagnostics in Cancer Testing Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
• 7.6 Korea Molecular Diagnostics in Cancer Testing Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
• 7.7 India Molecular Diagnostics in Cancer Testing Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
• 7.8 Southeast Asia Molecular Diagnostics in Cancer Testing Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
• 7.9 South America Molecular Diagnostics in Cancer Testing Production (K Units), Revenue (M USD) and Growth Rate 2013-2018

8 Global Molecular Diagnostics in Cancer Testing Market Performance (Consumption Point)

• 8.1 Global Molecular Diagnostics in Cancer Testing Consumption and Market Share by Regions 2013-2018
• 8.2 Global Molecular Diagnostics in Cancer Testing Consumption Value and Market Share by Regions 2013-2018
• 8.3 Global Molecular Diagnostics in Cancer Testing Price (USD/Unit) by Regions 2013-2018

9 Development Trend for Regions (Sales Point)

• 9.1 Global Molecular Diagnostics in Cancer Testing Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.2 China Molecular Diagnostics in Cancer Testing Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.3 USA Molecular Diagnostics in Cancer Testing Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.4 Europe Molecular Diagnostics in Cancer Testing Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.5 Japan Molecular Diagnostics in Cancer Testing Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.6 Korea Molecular Diagnostics in Cancer Testing Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.7 India Molecular Diagnostics in Cancer Testing Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.8 Southeast Asia Molecular Diagnostics in Cancer Testing Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.9 South America Molecular Diagnostics in Cancer Testing Sales and Growth, Sales Value and Growth Rate2013-2018

10 Upstream Source, Technology and Cost

• 10.1 Upstream Source
• 10.2 Technology
• 10.3 Cost

11 Channel Analysis

• 11.1 Market Channel
• 11.2 Distributors

12 Consumer Analysis

• 12.1 Application 1 Industry
• 12.2 Application 2 Industry

13 Market Forecast 2019-2024

• 13.1 Production (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
  • 13.1.1 Global Molecular Diagnostics in Cancer Testing Production (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
  • 13.1.2 Global Molecular Diagnostics in Cancer Testing Production (K Units) and Growth Rate 2019-2024
  • 13.1.3 China Molecular Diagnostics in Cancer Testing Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.4 USA Molecular Diagnostics in Cancer Testing Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.5 Europe Molecular Diagnostics in Cancer Testing Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.6 Japan Molecular Diagnostics in Cancer Testing Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.7 Korea Molecular Diagnostics in Cancer Testing Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.8 India Molecular Diagnostics in Cancer Testing Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.9 Southeast Asia Molecular Diagnostics in Cancer Testing Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.10 South America Molecular Diagnostics in Cancer Testing Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 13.2 Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.1 Global Molecular Diagnostics in Cancer Testing Consumption and Market Share by Regions 2019-2024
  • 13.2.2 Global Molecular Diagnostics in Cancer Testing Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.3 China Molecular Diagnostics in Cancer Testing Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.4 USA Molecular Diagnostics in Cancer Testing Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.5 Europe Molecular Diagnostics in Cancer Testing Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.6 Japan Molecular Diagnostics in Cancer Testing Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.7 Korea Molecular Diagnostics in Cancer Testing Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.8 India Molecular Diagnostics in Cancer Testing Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.9 Southeast Asia Molecular Diagnostics in Cancer Testing Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.10 South America Molecular Diagnostics in Cancer Testing Sales, Sales Value and Growth Rate 2019-2024
• 13.3 Production (K Units), Revenue (M USD) by Types 2019-2024
  • 13.3.1 Overall Market Performance
  • 13.3.2 Type I Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.3.3 Type II Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 13.4 Sales by Application 2019-2024
  • 13.4.1 Overall Market Performance
  • 13.4.2 Application 1 Sales and and Growth Rate 2019-2024
  • 13.4.3 Application 2 Sales and and Growth Rate 2019-2024
• 13.5 Price (USD/Unit) and Gross Profit
  • 13.5.1 Global Molecular Diagnostics in Cancer Testing Price (USD/Unit) Trend 2019-2024
  • 13.5.2 Global Molecular Diagnostics in Cancer Testing Gross Profit Trend 2019-2024

14 Conclusion